RT Journal Article
SR Electronic
T1 The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.02.20020016
DO 10.1101/2020.02.02.20020016
A1 Stephen A. Lauer
A1 Kyra H. Grantz
A1 Qifang Bi
A1 Forrest K. Jones
A1 Qulu Zheng
A1 Hannah Meredith
A1 Andrew S. Azman
A1 Nicholas G Reich
A1 Justin Lessler
YR 2020
UL http://medrxiv.org/content/early/2020/02/04/2020.02.02.20020016.abstract
AB A novel human coronavirus (2019-nCoV) was identified in China in December, 2019. There is limited support for many of its key epidemiologic features, including the incubation period, which has important implications for surveillance and control activities. Here, we use data from public reports of 101 confirmed cases in 38 provinces, regions, and countries outside of Wuhan (Hubei province, China) with identifiable exposure windows and known dates of symptom onset to estimate the incubation period of 2019-nCoV. We estimate the median incubation period of 2019-nCoV to be 5.2 days (95% CI: 4.4, 6.0), and 97.5% of those who develop symptoms will do so within 10.5 days (95% CI: 7.3, 15.3) of infection. These estimates imply that, under conservative assumptions, 64 out of every 10,000 cases will develop symptoms after 14 days of active monitoring or quarantine. Whether this risk is acceptable depends on the underlying risk of infection and consequences of missed cases. The estimates presented here can be used to inform policy in multiple contexts based on these judgments.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was provided for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code and data for this manuscript is available on github. https://doi.org/10.5281/zenodo.3634049